-
December 02, 2025
David M. Krinsky of Williams & Connolly LLP's life sciences practice represented Pfizer in patent infringement litigation filed by companies like Moderna and Enanta Pharmaceuticals Inc., and won a victory for Merck before the Federal Circuit, earning him a spot as one of the 2025 Law360 Life Sciences MVPs.
-
December 01, 2025
Sally Wagner Partin of Sidley Austin LLP represented Stryker Corp. in its $4.9 billion acquisition of the maker of medical technology used to remove blood clots without the need for clot-dissolving drugs, earning her a spot as one the 2025 Law360 Life Sciences MVPs.
-
November 26, 2025
Abigail Gregor of Ropes & Gray LLP advised Bain Capital on the formation of a new biopharmaceutical company focused on autoimmune disease treatments and AbbVie on its acquisition of a cell therapy developer in a potentially $2.1 billion deal, earning her a spot as one of the 2025 Law360 Life Sciences MVPs.
-
November 25, 2025
Mahvesh A. Qureshi, a life sciences partner at Hogan Lovells, advised her client through a deal to acquire Anthos Therapeutics, a biopharmaceutical company that developed a unique stroke treatment, in a transaction that could total $3.1 billion, and led Merck on its up to $1.3 billion purchase of a novel autoimmune drug, earning her a spot as one of the 2025 Law360 Life Sciences MVPs.
-
November 24, 2025
Charity Williams, a partner in Cooley LLP's life sciences corporate partnering and licensing practice, guided transformative pharmaceutical deals in 2025, including Capstan Therapeutics' $2.1 billion sale to AbbVie, Esobiotec's $1 billion sale to AstraZeneca and Advanced Instruments' $2.2 billion acquisition of Nova Biomedical, earning her a spot as one of the 2025 Law360 Life Sciences MVPs.
-
November 10, 2025
The attorneys chosen as Law360's 2025 MVPs have distinguished themselves from their peers by securing significant achievements in high-stakes litigation, complex global matters and record-breaking deals.
-
November 25, 2024
Lila Hope of Cooley LLP shepherded SystImmune Inc.'s $8.4 billion collaboration with Bristol Myers Squibb Co. and advised Foreseen Biotechnology on its $1 billion licensing agreement with Ipsen, earning her a spot among the 2024 Law360 Life Sciences MVPs.
-
November 22, 2024
Graham Robinson of Skadden Arps Slate Meagher & Flom LLP represented Iveric Bio in its $5.9 billion sale to global pharmaceutical company Astellas Pharma Inc., earning him a spot among the 2024 Law360 Life Sciences MVPs.
-
November 21, 2024
Douglas Cogen of Fenwick & West LLP's life sciences practice guided cardiovascular device company Shockwave Medical through a record-breaking acquisition by Johnson & Johnson, while he simultaneously shepherded multiple biopharma companies through multibillion-dollar deals, earning him recognition as a 2024 Law360 Life Sciences MVPs.
-
November 20, 2024
David I. Berl of Williams & Connolly LLP's patent litigation practice helped win a first-of-its-kind trial victory on behalf of Regeneron Pharmaceuticals by employing a novel legal strategy that allowed the biotech giant to quickly adjudicate its patent rights to an eye care medicine, earning him a spot as one of the 2024 Law360 Life Sciences MVPs.
-
November 19, 2024
Catherine Dargan of Covington & Burling LLP represented Bristol Myers Squibb Co. in its $14 billion acquisition of the company that developed Cobenfy — the first new drug in 35 years to be approved by the Food and Drug Administration for treating schizophrenia — earning her a spot among the 2024 Law360 Life Sciences MVPs.
-
November 18, 2024
Amanda Austin of Ropes & Gray's life sciences practice guided Pfizer through its $7 billion deal with Flagship Pioneering, advised Fulcrum Therapeutics in its blockbuster collaboration with Sanofi, and was lead counsel to Ginkgo Bioworks, earning her a spot as one of the 2024 Law360 Life Sciences MVPs.
-
October 18, 2024
The attorneys chosen as Law360's 2024 MVPs have distinguished themselves from their peers by securing hard-earned successes in high-stakes litigation, complex global matters and record-breaking deals.
-
October 20, 2023
George Lombardi of Winston & Strawn LLP has spent most of the last year in trials, collecting a number of wins and earning himself a spot among Law360's 2023 Life Sciences MVPs.
-
October 19, 2023
Matt Hurd of Sullivan & Cromwell LLP recently led Pfizer's acquisition of Seagen, a global biotech company specializing in cancer medicines, in a $43 billion all-cash deal, earning him a spot among Law360's 2023 Life Sciences MVPs.
-
October 18, 2023
Krishna Veeraraghavan of Paul Weiss Rifkind Wharton & Garrison LLP is leading home health provider Amedisys Inc. in its $3.3 billion acquisition by a UnitedHealth Group subsidiary and advised Amazon in its $3.9 billion acquisition of One Medical, earning him a spot among Law360's 2023 Life Sciences MVPs.
-
October 17, 2023
Eric Dittmann of Paul Hastings LLP shepherded Mitsubishi Tanabe Pharma Corp. through its win over Novartis Pharma AG after a four-year multibillion-dollar royalty battle and represented L'Oreal in protecting its skincare business after a suit filed by the University of Massachusetts Medical School and Carmel Laboratories threatened 180 products, earning him a spot as one of Law360's 2023 Life Sciences MVPs.
-
October 16, 2023
David Bauer of Davis Polk & Wardwell LLP advised Cellular Biomedicine Group on its licensing agreement with Janssen, in order to bring new cancer treatments outside of China, which earned him a spot among Law360's 2023 Life Sciences MVPs.
-
October 01, 2023
The attorneys chosen as Law360's 2023 MVPs have distinguished themselves from their peers by securing hard-earned successes in high-stakes litigation, complex global matters and record-breaking deals.
-
September 28, 2022
David Berl of Williams & Connolly LLP has spent much of the last year arguing and winning before the Federal Circuit, including securing an appellate win for AstraZeneca over a generic-drug dispute for its flagship asthma drug Symbicort, earning him a spot among Law360's 2022 Life Sciences MVPs.
-
September 27, 2022
Adam Acosta of White & Case LLP's life sciences practice has guided various health care giants through high-stakes litigation, including helping client AbbVie Inc. escape two antitrust class action complaints over hypertension medication Bystolic, earning him a spot among Law360's 2022 Life Sciences MVPs.
-
September 26, 2022
As a pair, David Bilsker and David Perlson of Quinn Emanuel Urquhart & Sullivan LLP spent the last year at the helm of a Chinese biotech giant's legal war over DNA patents against Illumina, earning them a spot among Law360's 2022 Life Science MVPs.
-
September 23, 2022
Throughout the past year, Amy L. Toro of Covington & Burling LLP led life sciences companies like Sanofi and AstraZeneca through deals worth well into the billions, earning her a spot among Law360's 2022 Life Sciences MVPs.
-
September 02, 2022
The attorneys chosen as Law360's 2022 MVPs have distinguished themselves from their peers by securing hard-earned successes in high-stakes litigation, complex global matters and record-breaking deals.
-
September 23, 2021
Sharon Robertson of Cohen Milstein Sellers & Toll PLLC has waged a number of legal battles in pay-for-delay schemes this year, earning her a spot among Law360's 2021 Life Sciences MVPs.